PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,000 | -42.9% | 2,190 | -60.1% | 0.00% | – |
| Q1 2021 | $14,000 | -12.5% | 5,490 | -11.7% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 6,215 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -45.8% | 6,215 | -19.9% | 0.00% | – |
| Q2 2020 | $24,000 | +50.0% | 7,757 | +0.2% | 0.00% | – |
| Q1 2020 | $16,000 | -54.3% | 7,740 | -19.0% | 0.00% | – |
| Q4 2019 | $35,000 | +34.6% | 9,553 | +23.5% | 0.00% | – |
| Q3 2019 | $26,000 | -23.5% | 7,734 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +30.8% | 7,734 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +23.8% | 7,734 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -51.2% | 7,734 | 0.0% | 0.00% | – |
| Q3 2018 | $43,000 | +10.3% | 7,734 | 0.0% | 0.00% | – |
| Q2 2018 | $39,000 | -13.3% | 7,734 | +17.9% | 0.00% | – |
| Q1 2018 | $45,000 | -10.0% | 6,560 | 0.0% | 0.00% | – |
| Q4 2017 | $50,000 | +72.4% | 6,560 | +28.7% | 0.00% | – |
| Q3 2017 | $29,000 | +11.5% | 5,097 | 0.0% | 0.00% | – |
| Q2 2017 | $26,000 | – | 5,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |